Merck (MRK) Cash from Financing Activities (2009 - 2026)
Merck (MRK) reported Cash from Financing Activities of -$3.0 billion for Q1 2026, up 48.2% year-over-year from -$2.0 billion in Q1 2025, and down 162.74% on a QoQ basis from $4.8 billion in Q4 2025.
Merck (MRK) has 18 years of Cash from Financing Activities data on file, last reported at -$3.0 billion in Q1 2026.
- Quarterly Cash from Financing Activities rose 48.2% year-over-year to -$3.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $852.0 million (up 108.54% YoY) and the FY2025 annual result came in at -$1.9 billion, up 72.67% from the prior year.
- Cash from Financing Activities retreated to -$3.0 billion in Q1 2026 per MRK's latest filing, from $4.8 billion in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $4.8 billion in Q4 2025 and bottomed at -$5.8 billion in Q1 2025.
- The 5-year median for Cash from Financing Activities is -$2.4 billion (2024), against an average of -$1.5 billion.
- The widest annual swing landed in 2023, when Cash from Financing Activities surged 311.48%; it then slumped 392.43% in 2025.
- Tracing MRK's Cash from Financing Activities over 5 years: stood at -$1.6 billion in 2022, then sank by 44.47% to -$2.2 billion in 2023, then tumbled by 34.03% to -$3.0 billion in 2024, then soared by 257.89% to $4.8 billion in 2025, then tumbled by 162.74% to -$3.0 billion in 2026.
- Per Business Quant, the three latest MRK Cash from Financing Activities figures stand at -$3.0 billion (Q1 2026), $4.8 billion (Q4 2025), and $2.6 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | -3.47 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 530.00 Mn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 919.00 Mn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -2.98 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 1.44 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | -4.24 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -2.86 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -1.56 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.98 Bn |
| Mar 31, 2026 | -2.98 Bn |
| Dec 31, 2025 | 4.75 Bn |
| Dec 31, 2025 | 4.75 Bn |
| Sep 30, 2025 | 2.64 Bn |
| Sep 30, 2025 | 2.64 Bn |
| Jun 30, 2025 | -3.56 Bn |
| Jun 30, 2025 | -3.56 Bn |
| Mar 31, 2025 | -5.76 Bn |
| Mar 31, 2025 | -5.76 Bn |
| Dec 31, 2024 | -3.01 Bn |
| Dec 31, 2024 | -3.01 Bn |
| Sep 30, 2024 | -2.43 Bn |
| Sep 30, 2024 | -2.43 Bn |
| Jun 30, 2024 | 1.22 Bn |
| Jun 30, 2024 | 1.22 Bn |
| Mar 31, 2024 | -2.81 Bn |
| Mar 31, 2024 | -2.81 Bn |
| Dec 31, 2023 | -2.25 Bn |
| Dec 31, 2023 | -2.25 Bn |
| Sep 30, 2023 | -4.27 Bn |
| Sep 30, 2023 | -4.27 Bn |
| Jun 30, 2023 | 3.76 Bn |
| Jun 30, 2023 | 3.76 Bn |
| Mar 31, 2023 | -2.05 Bn |
| Mar 31, 2023 | -2.05 Bn |
| Dec 31, 2022 | -1.55 Bn |
| Dec 31, 2022 | -1.55 Bn |
| Sep 30, 2022 | -2.70 Bn |
| Sep 30, 2022 | -2.70 Bn |
| Jun 30, 2022 | -1.78 Bn |
| Jun 30, 2022 | -1.78 Bn |
| Mar 31, 2022 | -3.09 Bn |
| Mar 31, 2022 | -3.09 Bn |
| Dec 31, 2021 | 5.21 Bn |
| Dec 31, 2021 | 5.21 Bn |
| Sep 30, 2021 | -2.27 Bn |
| Sep 30, 2021 | -2.27 Bn |
| Jun 30, 2021 | 2.26 Bn |
| Jun 30, 2021 | 2.26 Bn |
| Mar 31, 2021 | -2.10 Bn |
| Mar 31, 2021 | -2.10 Bn |
| Dec 31, 2020 | 1.37 Bn |
| Dec 31, 2020 | 1.37 Bn |
| Sep 30, 2020 | -3.85 Bn |
| Sep 30, 2020 | -3.85 Bn |
| Jun 30, 2020 | 1.14 Bn |
| Jun 30, 2020 | 1.14 Bn |
| Mar 31, 2020 | -1.49 Bn |
| Mar 31, 2020 | -1.49 Bn |
| Dec 31, 2019 | -2.01 Bn |
| Dec 31, 2019 | -2.01 Bn |
| Sep 30, 2019 | -3.15 Bn |
| Sep 30, 2019 | -3.15 Bn |
| Jun 30, 2019 | -2.08 Bn |
| Jun 30, 2019 | -2.08 Bn |
| Mar 31, 2019 | -1.61 Bn |
| Mar 31, 2019 | -1.61 Bn |
| Dec 31, 2018 | -5.57 Bn |
| Dec 31, 2018 | -5.57 Bn |
| Sep 30, 2018 | -1.91 Bn |
| Sep 30, 2018 | -1.91 Bn |
| Jun 30, 2018 | -2.97 Bn |
| Jun 30, 2018 | -2.97 Bn |
| Mar 31, 2018 | -2.72 Bn |
| Mar 31, 2018 | -2.72 Bn |
| Dec 31, 2017 | -5.79 Bn |
| Dec 31, 2017 | -5.79 Bn |
| Sep 30, 2017 | 536.00 Mn |
| Sep 30, 2017 | 536.00 Mn |
| Jun 30, 2017 | -6.22 Bn |
| Jun 30, 2017 | -6.22 Bn |
| Mar 31, 2017 | 1.46 Bn |
| Mar 31, 2017 | 1.46 Bn |
| Dec 31, 2016 | -1.98 Bn |
| Dec 31, 2016 | -1.98 Bn |
| Sep 30, 2016 | -835.00 Mn |
| Sep 30, 2016 | -835.00 Mn |
| Jun 30, 2016 | -3.37 Bn |
| Jun 30, 2016 | -3.37 Bn |
| Mar 31, 2016 | -2.87 Bn |
| Mar 31, 2016 | -2.87 Bn |
| Dec 31, 2015 | -2.41 Bn |
| Dec 31, 2015 | -2.41 Bn |
| Sep 30, 2015 | -2.54 Bn |
| Sep 30, 2015 | -2.54 Bn |
| Jun 30, 2015 | -5.60 Bn |
| Jun 30, 2015 | -5.60 Bn |
| Mar 31, 2015 | 5.16 Bn |
| Mar 31, 2015 | 5.16 Bn |
| Dec 31, 2014 | -9.77 Bn |
| Dec 31, 2014 | -9.77 Bn |
| Sep 30, 2014 | 1.28 Bn |
| Sep 30, 2014 | 1.28 Bn |
| Jun 30, 2014 | -8.37 Bn |
| Jun 30, 2014 | -8.37 Bn |
| Mar 31, 2014 | 1.62 Bn |
| Mar 31, 2014 | 1.62 Bn |
| Dec 31, 2013 | -2.62 Bn |
| Dec 31, 2013 | -2.62 Bn |
| Sep 30, 2013 | -2.92 Bn |
| Sep 30, 2013 | -2.92 Bn |
| Jun 30, 2013 | 970.00 Mn |
| Jun 30, 2013 | 970.00 Mn |
| Mar 31, 2013 | -1.42 Bn |
| Mar 31, 2013 | -1.42 Bn |
| Dec 31, 2012 | -1.22 Bn |
| Dec 31, 2012 | -1.22 Bn |
| Sep 30, 2012 | -738.00 Mn |
| Sep 30, 2012 | -738.00 Mn |
| Jun 30, 2012 | -586.00 Mn |
| Jun 30, 2012 | -586.00 Mn |
| Mar 31, 2012 | -725.00 Mn |
| Mar 31, 2012 | -725.00 Mn |
| Dec 31, 2011 | -2.23 Bn |
| Dec 31, 2011 | -2.23 Bn |
| Sep 30, 2011 | -2.24 Bn |
| Sep 30, 2011 | -2.24 Bn |
| Jun 30, 2011 | -1.26 Bn |
| Jun 30, 2011 | -1.26 Bn |
| Mar 31, 2011 | -1.17 Bn |
| Mar 31, 2011 | -1.17 Bn |
| Dec 31, 2010 | -1.30 Bn |
| Dec 31, 2010 | -1.30 Bn |
| Sep 30, 2010 | -1.63 Bn |
| Sep 30, 2010 | -1.63 Bn |
| Jun 30, 2010 | -3.46 Bn |
| Jun 30, 2010 | -3.46 Bn |
| Mar 31, 2010 | 942.00 Mn |
| Mar 31, 2010 | 942.00 Mn |
| Dec 31, 2009 | -1.85 Bn |
| Dec 31, 2009 | -1.85 Bn |
| Sep 30, 2009 | -2.37 Bn |
| Sep 30, 2009 | -2.37 Bn |
| Jun 30, 2009 | 2.98 Bn |
| Jun 30, 2009 | 2.98 Bn |
| Mar 31, 2009 | -391.90 Mn |
| Mar 31, 2009 | -391.90 Mn |